BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 18, 2010
View Archived Issues
Ensemble Discovery claims novel TNF-alpha inhibitors
Read More
Novel PBR ligands disclosed by University of Sydney
Read More
Novel tryptase beta inhibitors claimed by sanofi-aventis
Read More
Merck & Co. and Scynexis claim novel antifungal agents
Read More
Potential biomarkers for SR-13668 activity identified / News in Context
Read More
Hetero Research Foundation claims new sodium/glucose cotransporter 2 inhibitors
Read More
Clinical data reported on ER dipyridamole/aspirin in ischemic stroke/transient ischemic attack
Read More
Novel antibody-drug conjugate ASG-5ME shows preclinical potential for treatment of cancer
Read More
Results from ongoing phase I/II trial of HE-3235 in CRPC disclosed
Read More
Encouraging preliminary phase II data reported on Ad5-PSA vaccine in prostate cancer
Read More
FDA accepts for review NDA for fixed-dose Onglyza/metformin combination in type 2 diabetes
Read More
Acucela and Otsuka receive FDA fast track status for ACU-4429 in dry AMD
Read More
ALS Therapy Development Institute and Aestus to test potential ALS treatments
Read More
Zogenix begins pivotal phase III trial of ZX-002 for pain
Read More
Icagen reports phase IIa results on ICA-105665 in photosensitive epilepsy
Read More
Abraxis' Abraxane meets primary endpoint in phase III non-small cell lung cancer trial
Read More
Human Genome Sciences reports phase II data on mapatumumab in non-small cell lung cancer
Read More
Protalix initiates phase I trial of PRX-105 acetylcholinesterase for biodefense indications
Read More
Alkermes begins multidose phase I ALKS-37 trial in opioid-induced constipation
Read More
Cyplasin initiates hepatitis product development program
Read More
Nabi initiates second phase III trial of nicotine conjugate NicVAX vaccine
Read More
Novartis receives E.U. approval for meningococcal Menveo vaccine
Read More
Cangene receives European approval for ImmunoGam hepatitis B product
Read More
Antisoma commences phase IIb trial of AS-1411 in AML
Read More
Vectura and Sandoz revise VR-315 agreement for U.S.
Read More